Pityriasis Rotunda

Earn CME/CE in your profession:


Continuing Education Activity

Pityriasis rotunda is an uncommon acquired dermatosis related to a disorder of keratinization. It is characterized by hyperpigmented or hypopigmented, sharply defined, circular, or oval scaly plaques of variable size, which develop on the trunk and proximal parts of the limbs. Pityriasis rotunda, not commonly encountered in some regions of the world, is not always easy to diagnose. This activity will assist practitioners in recognizing when to consider this diagnosis and how to manage it. This activity highlights the critical role of the interprofessional care team in caring for patients with pityriasis rotunda.

Objectives:

  • Determine some of the signs and symptoms that patients with pityriasis rotunda may exhibit.

  • Apply the differential diagnosis of pityriasis rotunda.

  • Determine how to manage a patient affected by pityriasis rotunda properly.

  • Communicate the role of interprofessional team members in optimizing collaboration and communication to ensure patients with pityriasis rotunda receive high-quality care, which will lead to enhanced outcomes.

Introduction

Pityriasis rotunda is an uncommon acquired dermatosis related to a keratinization disorder described first in 1906. This dermatosis was called pityriasis circinata and "pseudo-ichtyose acquise en taches circulaires." It is characterized by hyperpigmented or hypopigmented, sharply defined, circular, or oval scaly plaques of variable size, which develop on the trunk and proximal parts of the limbs. Pityriasis rotunda, not commonly encountered in some regions of the world, is not always easy to diagnose.[1][2][3]

Etiology

The etiology of pityriasis rotunda is not established. Authors have attached it to various disorders of keratinization, such as ichthyosis vulgaris, late-onset congenital ichthyosis, and acquired ichthyosis. Pityriasis rotunda is also considered a potential paraneoplastic dermatosis since it may be observed during certain malignancies, mainly hepatocellular carcinoma in South African black patients, but also the following:

  • IgG myeloma, multiple myeloma
  • Acute myeloid leukemia
  • Chronic myeloid leukemia
  • Adenocarcinoma of the prostate
  • Esophagus carcinoma
  • Gastric carcinoma
  • Squamous cell carcinoma of the palate.

Pityriasis rotunda is also associated with several systemic diseases, such as:

  • Malnutrition
  • Diabetes mellitus
  • Infections (tuberculosis, leprosy, osteitis)
  • Hepatic diseases such as cirrhosis
  • Chronic obstructive pulmonary disease and recurrent pulmonary infections
  • Heart disease
  • Female genital tract anomalies (ovarian cysts and fibroids)
  • Glucose-6-phosphate dehydrogenase deficiency (favism)
  • Chronic diarrhea
  • Scleroderma
  • Sarcoidosis
  • Hormonal disorders such as hyperprolactinemia.

However, researchers have not eliminated the idea that the association of some of these conditions associated with pityriasis rotunda, especially favism, could be due to chance.[4][5][6][7]

Epidemiology

Pityriasis rotunda affects both genders equally, although certain authors noticed a slight female predominance. The age for the diagnosis ranges from 20 to 45 years, with extremes of 2 and 87 years. There is a particular racial and geographic distribution for pityriasis rotunda. Most cases are reported in Japan and among West Indian and South African blacks. Case reports of pityriasis rotunda in black Americans are less common, and the frequency of the disease on the North American continent is not known. Cases of pityriasis rotunda among Caucasians are also rare. Mainly, cases are reported in Mediterranean patients, especially from Sardinia, Italy. Familial cases may also be observed and likely have a hereditary determinism which may be an autosomal dominant transmission.

Pathophysiology

Hashimoto et al described a diminished expression of loricrin and filaggrin in pityriasis rotunda lesions. According to Yoneda et al, a complete absence of the profilaggrin-N terminus domain is observed in the lesional skin. Makino et al reported a decrease in the expression of epidermal filaggrin 2, as seen in ichthyosis vulgaris, atopic dermatitis, and psoriasis vulgaris.

Histopathology

Histopathology of pityriasis rotunda lesions can reveal variable findings, including hyperkeratosis, which is mainly ortho-keratotic but can be para-keratotic, with plugs observed within hair follicles, elongated rete ridges, a diminished or absent stratum granulosum, slight spongiosis, enhanced pigmentation of the basal layer, pigmentary incontinence, and perivascular infiltrate of small lymphocytes. Periodic acid-Schiff (PAS) stain for fungus is negative. These changes are similar to those observed in ichthyosis vulgaris. However, the histopathological aspect may be normal.

Grimalt et al performed an ultrastructural study on pityriasis rotunda lesional skin biopsies. They noted the existence within the epidermis of vacuoles of lipid and crystal-like inclusions. Granules of keratohyalin were normal, and keratinosomes were increased. The stratum granulosum was reduced to 1 layer. The cementing substance connecting corneocytes was abundant. These findings suggest that pityriasis rotunda was more related to congenital ichthyosis than ichthyosis vulgaris.

History and Physical

The diagnosis of pityriasis rotunda is usually based on clinical examination. Skin lesions are generally asymptomatic or mildly symptomatic. Pityriasis rotunda plaques are scaly, dry, sharply defined, and round, with prominent hair follicles but no inflammatory erythema. Scales may be highlighted by scratching the plaques. The lesions appear hypopigmented in fair-skinned patients and hyperpigmented in dark-skinned patients. The plaques of pityriasis rotunda may be confluent. Their size is variable (1 cm to more than 20 cm), and their number ranges from 1 to dozens but rarely exceeds 100. Pityriasis rotunda affects mainly the trunk (back and abdomen), buttocks, and proximal parts of the limbs (thighs and arms). The face, hands, and feet are usually not involved. In some patients, associated skin lesions of ichthyosis vulgaris may be observed. A familial history of ichthyosis vulgaris has been reported in certain patients with pityriasis rotunda.[8][9]

Grimalt et al proposed a classification of pityriasis rotunda. The first subtype consists of less than 30 hyperpigmented patches, mainly in black and Asian persons. No similar familial cases are seen in this subtype, but associated diseases are frequently described, such as malignancies (solid tumors and hemopathies), systemic diseases, and infections. A second subtype is characterized by more than 30 hypopigmented patches, occurring mainly in white patients with a familial history of similar skin lesions. There usually is no underlying disease. This classification is schematic since overlap cases have been reported. The clinical differential diagnosis includes tinea versicolor, erythrasma, tinea corporis, nummular eczema, early-stage mycosis fungoides, fixed drug reaction, pityriasis rosea, pityriasis alba, figurate erythema, and leprosy.

Evaluation

Mycological examination of scaly material removed from lesional skin (direct microscopy using potassium hydroxide and fungal culture) is useful to rule out a dermatomycosis. Wood light examination is used if erythrasma is suspected.

Treatment / Management

Management of pityriasis rotunda is often challenging. Topical corticosteroids, antifungal agents, emollients, tars, and keratolytic topicals (salicylic acid and lactic acid) are poorly efficient. Retinoids, either topicals (retinoic acid and tazarotene) or oral (etretinate) have been used with little or no success in pityriasis rotunda. Treatment with vitamin D3 analogs such as calcipotriol leads to a progressive improvement in the lesions in a few patients. However, for patients with comorbidities, successful treatment of the underlying disease often leads to remission of pityriasis rotunda lesions.

Differential Diagnosis

The differential diagnoses for pityriasis rotunda include the following:

  • Erythrasma
  • Leprosy
  • Parapsoriasis
  • Pityriasis alba 
  • Pityriasis rosea
  • Plaque psoriasis
  • Sarcoidosis
  • Tinea corporis
  • Tinea cruris
  • Tinea versicolor

Pearls and Other Issues

Skin lesions of pityriasis rotunda have a chronic course and can persist for months to years, with alternating periods of exacerbation (especially during winter or pregnancy) and remission. Follow-up of pityriasis rotunda skin lesions without treatment is the other option because of possible spontaneous resolution. Since underlying diseases, mainly malignancies, have been associated with pityriasis rotunda, physicians should be aware of the importance of ruling out such diseases based on anamnesis, physical examination, and appropriate investigations.

Enhancing Healthcare Team Outcomes

Pityriasis rotunda is a rare skin disorder that is not easy to diagnose. The condition may be seen by the primary care provider, but because of the complexity of the diagnosis, it is best managed by a dermatologist. Once diagnosed, the management of pityriasis rotunda is often challenging. Topical corticosteroids, antifungal agents, emollients, tars, and keratolytic topicals (salicylic acid and lactic acid) are poorly efficient. Retinoids, either topicals (retinoic acid and tazarotene) or oral (etretinate) have been used with little or no success in pityriasis rotunda. Treatment with vitamin D3 analogs such as calcipotriol leads to a progressive improvement in the lesions in a few patients. The skin condition can take months or even years to disappear. However, for patients with comorbidities, successful treatment of the underlying disease often leads to remission of pityriasis rotunda lesions. Because of the few cases, there are no evidence-based guidelines on managing this disorder.


Details

Author

Talel Badri

Editor:

Wissem Hafsi

Updated:

9/12/2022 9:14:02 PM

References


[1]

Al-Refu K, Al-Tarawneh A, Odeibat H. Pityriasis rotunda. A clinical study in Jordan: experience of 10 years. International journal of dermatology. 2018 Jul:57(7):759-762. doi: 10.1111/ijd.13994. Epub 2018 May 17     [PubMed PMID: 29774541]


[2]

Suzuki Y, Aoshima M, Fujiyama T, Ito T, Tokura Y. Pityriasis rotunda associated with acute myeloid leukemia. The Journal of dermatology. 2018 Jan:45(1):105-106. doi: 10.1111/1346-8138.13802. Epub 2017 Mar 29     [PubMed PMID: 28370261]


[3]

Vaccaro M,Salpietro C,Foti A,Borgia F,Lentini M,Cannavò SP, Pityriasis rotunda with recurrent respiratory infections. Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia. 2017 Apr;     [PubMed PMID: 28166620]


[4]

Lefkowitz EG, Natow AJ. Pityriasis Rotunda: A Case Report of Familial Disease in an American-Born Black Patient. Case reports in dermatology. 2016 Jan-Apr:8(1):71-4. doi: 10.1159/000445043. Epub 2016 Mar 18     [PubMed PMID: 27065844]

Level 3 (low-level) evidence

[5]

Pinos-León V, Núñez M, Salazar M, Solís-Bowen V. Pityriasis Rotunda and Hyperprolactinemia. Actas dermo-sifiliograficas. 2016 Jul-Aug:107(6):535-7. doi: 10.1016/j.ad.2015.10.016. Epub 2016 Mar 19     [PubMed PMID: 27006018]


[6]

Makino T, Mizawa M, Seki Y, Hayashi M, Shimizu T. Decreased filaggrin-2 expression in the epidermis in a case of pityriasis rotunda. Clinical and experimental dermatology. 2016 Mar:41(2):215-7. doi: 10.1111/ced.12716. Epub 2015 Jul 20     [PubMed PMID: 26189536]

Level 3 (low-level) evidence

[7]

van Heerden T, Webb MJ, Barrett CL. Pityriasis rotunda as an incidental paraneoplastic finding in two patients with multiple myeloma. Clinical and experimental dermatology. 2014 Aug:39(6):734-7. doi: 10.1111/ced.12396. Epub 2014 Jul 1     [PubMed PMID: 24985090]


[8]

Zur RL,Shapero J,Shapero H, Pityriasis rotunda diagnosed in Canada: case presentation and review of the literature. Journal of cutaneous medicine and surgery. 2013 Nov-Dec;     [PubMed PMID: 24138982]

Level 3 (low-level) evidence

[9]

Mirsky L, Watters K, Jafarian F. Chronic hyperpigmented scaly plaques. Pityriasis rotunda (PR). Archives of dermatology. 2012 Sep:148(9):1073-8. doi: 10.1001/archdermatol.2012.1494. Epub     [PubMed PMID: 22986863]